Rukia Ahmed, left, and Adam Mgaya gather larvae of pesticide-resistant mosquitoes in a cattle pasture in the Zenet region in Tanzania in April, 2017. They reared the larvae of these malaria-spreading Anopheles gambiae and Anopheles arabiensis mosquitoes to test an attract-and-kill strategy using naturally occurring chemicals that mimic the smell of nectar that they feed upon. Courtesy of Jesse Saroli, ISCA Technologies
Mosquitoes, mostly through the transmission of malaria, are the deadliest animals on Earth. Malaria claims the lives of hundreds of thousands of people each year. A Riverside, Calif., biotech firm is working on several innovations to stop outbreaks of malaria-spreading mosquitoes before they occur. One exploits the mosquito's hunger for nectar to attract and kill them before they suck blood. A second tricks mosquitoes into biting cows that are immune from malaria and carry a medication that kills these pests. A third attracts and kills young mosquito larvae.
The American Chemical Society will showcase these and other innovations under development by ISCA Technologies during the society's conference Aug. 20-24 in Washington, D.C.
These breakthroughs put to work pheromones and other attractants already found in nature to manipulate the deadliest disease-carrying pests without harming the environment. These innovations reduce pesticide applications by orders of magnitude or in some cases completely replace them.
"We want to help eradicate vector borne diseases and all the suffering that they cause. We are contributing by creating inexpensive smart green products that change the way vectors like mosquitoes, ticks and flies behave, killing them before they will bite and transmit diseases," said Agenor Mafra-Neto, CEO, and founder of ISCA Technologies, who will be presenting at the ACS conference.
Climate change is creating a greater urgency for such innovations:
As the planet warms, greater expanses of the globe will not freeze in the winter and eliminate in many areas an important check on mosquito populations.
More extreme storm events increase flooding, which will result in ideal conditions for mosquito breeding since their larvae hatch and grow in stagnant water.
Extreme weather also will damage roads and other infrastructure and make it more difficult to respond to mosquito outbreaks.
Too often, curbing mosquito outbreaks with traditional pesticide sprays is like trying to put out a wildfire that is already out of control, as their populations spike following rainy weather. However, by targeting immature mosquitoes, an ISCA formulation called SPLAT BAC stops mosquitos before their numbers grow. It works preemptively by applying treatments to floodplains and other known water-gathering spots before the rainy seasons begin. An inert substrate containing the natural behavior-modifying attractants and a minute dose of a green larvicide sticks to vegetation, gravel, and rocks when applied to the dry, future mosquito breeding sites.
The formulation goes to work just after the rain arrives, which forms puddles and other aquatic habitats that mosquitoes need to reproduce. It then floats to the surface of the water, where one attractant lures pregnant mosquitoes and induces them to lay their eggs in the treated areas. As the larvae hatch, another attractant compels them to eat the naturally occurring bacteria species, Bacillus thuringiensis israelensis, or Bti, also in the formulation. The bacteria kills mosquito larvae but leaves unharmed all of the other non-target species.
The strategy stops the mosquito life cycle before the adult population can spike and efficiently spread diseases such as malaria, West Nile Virus, filariasis, Zika, and dengue. The environment is left unharmed because the substrate mixture is benign and the bacteria is not harmful to beneficial species, such as honey bees. Malaria alone in 2015 afflicted some 214 million people worldwide, causing an estimated 438,000 deaths, according to the World Health Organization.
ISCA's home facility in Riverside, Calif., has completed the laboratory work. Most of the field work will be done in California and Florida. Field trials also will be done in Tanzania in East Africa, Côte d'Ivoire in West Africa, and in Brazil, where mosquito-vectored diseases such as malaria, lymphatic filariasis, Zika and dengue are prevalent.
Another ISCA strategy is called the "Trojan Cow." This works by treating cattle and goats with a formulation that makes the livestock smell like people to mosquitoes. The odor entices malaria-carrying mosquitos to bite these animals, which are immune to the disease. A deworming medication in the cattle then kills the mosquitoes.
Mafra-Neto also will present on a sprayable attract-and-kill product called Vectrax that mimics the sweet smell of nectar that mosquitoes feed upon. This lures adult mosquitoes to a small quantity of insecticide that, upon being ingested, kills them without harming other wildlife, including bees and other pollinators. Since female mosquitoes must feed on nectar several times before seeking blood, Vectrax can eliminate them before they have the chance bite people, and spread diseases, such as malaria. However, unlike most other attractants, Vectrax also attracts and has effect on male mosquitoes, potentially doubling its efficacy. Large fields trials are now ongoing in the Muheza district of Tanzania, a region hit hard by endemic malaria.
Closer to home, deer ticks common in North America spread Lyme disease and other pathogens. So ISCA is developing a technology, SPLAT TK, that employs an attract-and-kill strategy similar to Vectrax. Using a blend of deer tick pheromones, it attracts ticks to a very small but still highly effective amount of pesticide. By attracting the ticks to small isolated point sources of pesticide, this attract-and-kill strategy stands to dramatically reduce the volume of pesticides used to control ticks, making for far safer controls in backyards, near schools, parks, trails and sensitive wildlife habitats.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.